Access here alternative investment news about Carisma Therapeutics Completes Series B Financing Totaling $59M
Venture Capital

Carisma Therapeutics Completes Series B Financing Totaling $59M

by prnewswire.com posted 1month ago 23 views
PHILADELPHIA, March 1, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today the second closing of its Series B equity financing, bringing the total amount raised in this round to $59...

In this article